Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
Background Ovarian stimulation (OS) for poor ovarian response (POR) patients is still a major challenge in assisted reproductive techniques. Aromatase inhibitors as co-treatment in antagonist protocol are suggested to these patients, but there are controversial reports. Objective To evaluate the eff...
Saved in:
Main Authors: | Ashraf Moini (Author), Zohreh Lavasani (Author), Ladan Kashani (Author), Maryam Farid Mojtahedi (Author), Nazila Yamini (Author) |
---|---|
Format: | Book |
Published: |
Shahid Sadoughi University of Medical Sciences,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: An RCT
by: Mahbod Ebrahimi, et al.
Published: (2017) -
Effect of intrauterine granulocyte-colony stimulating factor administration on in vitro fertilization outcome in women with moderate-to-severe endometriosis: An RCT
by: Ladan Kashani, et al.
Published: (2021) -
The effect of letrozole versus artificial hormonal endometrial preparation on pregnancy outcome after frozen-thawed embryos transfer cycles: a randomized clinical trial
by: Azadeh Hosseini-Najarkolaei, et al.
Published: (2020) -
Pregnancy outcome of "delayed start" GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study
by: Abbas Aflatoonian, et al.
Published: (2017) -
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
by: Moran Shapira, et al.
Published: (2020)